5-hydroxytryptamine receptor 2B — Drug Target

6 drugs 5 marketed 1 in Phase 3

All drugs that target 5-hydroxytryptamine receptor 2B — marketed and clinical-stage. Includes 6 drug classes acting on this target.

Drug classes

Antiarrhythmic · General Anesthetic [EPC] · Serotonin-4 Receptor Agonist · chloroxylenol · nalidixic acid · aclarubicin

Marketed (5)

Phase 3 pipeline (1)